Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Inflammation, insulin resistance, and type 2 diabetes: back to the future?

    Cefalu WT.

    Diabetes. 2009 Feb;58(2):307-8. No abstract available. PMID: 19171748 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Obesity: the two faces of fat.

    Powell K.

    Nature. 2007 May 31;447(7144):525-7. No abstract available. PMID: 17538594 [PubMed - indexed for MEDLINE]Related articles

    3.

    Resistin: can we resist its role in insulin resistance?

    Alzahrani AS.

    Ann Saudi Med. 2005 Jul-Aug;25(4):281-2. No abstract available. PMID: 16212118 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.

    Al-Harithy RN, Al-Ghamdi S.

    Ann Saudi Med. 2005 Jul-Aug;25(4):283-7.PMID: 16212119 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Inflammation: the link between insulin resistance, obesity and diabetes.

    Dandona P, Aljada A, Bandyopadhyay A.

    Trends Immunol. 2004 Jan;25(1):4-7. Review.PMID: 14698276 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

    Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.

    Diabetes Care. 2004 Aug;27(8):2033-40.PMID: 15277436 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Obesity, inflammation, and insulin resistance--a mini-review.

    Zeyda M, Stulnig TM.

    Gerontology. 2009;55(4):379-86. Epub 2009 Apr 8. Review.PMID: 19365105 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum resistin, adiposity, and insulin resistance in Saudi women: conflicting data or statistical flaws?

    Afifi M.

    Ann Saudi Med. 2006 Mar-Apr;26(2):156. No abstract available. PMID: 16761459 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Relationship between obesity, inflammation and insulin resistance: new concepts]

    Fève B, Bastard JP, Vidal H.

    C R Biol. 2006 Aug;329(8):587-97; discussion 653-5. Epub 2006 May 5. Review. French. PMID: 16860277 [PubMed - indexed for MEDLINE]Related articles

    10.

    Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus.

    Katsuki A, Urakawa H, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y.

    Eur J Endocrinol. 2004 Nov;151(5):573-7.PMID: 15538935 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes.

    Hegazi RA, Sutton-Tyrrell K, Evans RW, Kuller LH, Belle S, Yamamoto M, Edmundowicz D, Kelley DE.

    Obes Res. 2003 Dec;11(12):1597-605.PMID: 14694226 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pathogenesis of type 2 diabetes. Insulin resistance.

    Boden G.

    Endocrinol Metab Clin North Am. 2001 Dec;30(4):801-15, v. Review.PMID: 11727400 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance.

    Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA, Kirwan JP.

    Diabetes. 2009 Feb;58(2):337-43. Epub 2008 Nov 13.PMID: 19008343 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Stressed out about obesity and insulin resistance.

    de Luca C, Olefsky JM.

    Nat Med. 2006 Jan;12(1):41-2; discussion 42. No abstract available. PMID: 16397561 [PubMed - indexed for MEDLINE]Related articles

    15.

    Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

    Guilherme A, Virbasius JV, Puri V, Czech MP.

    Nat Rev Mol Cell Biol. 2008 May;9(5):367-77. Review.PMID: 18401346 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance.

    Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC.

    Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E906-16.PMID: 12959938 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.

    Winkler G, Salamon F, Salamon D, Speer G, Simon K, Cseh K.

    Diabetologia. 1998 Jul;41(7):860-1. No abstract available. PMID: 9686931 [PubMed - indexed for MEDLINE]Related articles

    18.

    Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue.

    Youn BS, Bang SI, Klöting N, Park JW, Lee N, Oh JE, Pi KB, Lee TH, Ruschke K, Fasshauer M, Stumvoll M, Blüher M.

    Diabetes. 2009 Mar;58(3):627-36. Epub 2008 Dec 3.PMID: 19056610 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    New concepts in the relationship obesity--non-insulin dependent diabetes mellitus.

    Björntorp P.

    Eur J Med. 1992 Apr;1(1):37-42. Review. No abstract available. PMID: 1341975 [PubMed - indexed for MEDLINE]Related articles

    20.

    Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance.

    Iwasaki T, Yoneda M, Nakajima A, Terauchi Y.

    Intern Med. 2007;46(19):1633-9. Epub 2007 Oct 1.PMID: 17917325 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data